Methods of enriching or amplifying nucleic acids in a sample from a patient with inflammatory bowel disease
US12391752B2 · kind B2 · utility
0Cited by
63References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 13, 2023 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Jun 25, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods, systems, and kits for selecting a patient for treatment with a therapeutic agent based on a presence of a genotype associated with a positive therapeutic response to the therapeutic agent. The therapeutic agent, in some embodiments, is an inhibitor of TL1A activity or expression, such as for example, an anti-TL1A antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.